Oxytocin in Male Reproduction

Oxytocin (OT) is widely recognised for its roles in lactation and parturition, yet a substantial body of evidence demonstrates that this nine-amino-acid neuropeptide is equally important in male reproductive physiology. From local synthesis within the testes to the regulation of spermatogenesis, epididymal contractility, prostatic function, and the neuroendocrine cascade of male sexual arousal, oxytocin occupies a central – and often under-appreciated – position in the male reproductive axis. This article reviews the peer-reviewed literature on oxytocin’s structure and function in male reproduction, drawing on animal models and human clinical data.

Oxytocin Synthesis in the Male Reproductive Tract

Testicular Production of Oxytocin

The discovery that oxytocin is synthesised locally within the testes transformed understanding of male reproductive endocrinology. Nicholson and Hardy (1992) demonstrated oxytocin mRNA expression in Leydig cells of the rat testis, establishing that OT production is not confined to the hypothalamic-neurohypophysial system. Subsequent immunohistochemical studies confirmed the presence of oxytocin in Leydig cells, Sertoli cells, and the epithelial lining of the epididymis across multiple species including humans (Frayne & Nicholson, 1998).

Testicular oxytocin operates in a paracrine and autocrine fashion – acting on neighbouring cells via locally expressed oxytocin receptors (OTRs). The concentration of OT in testicular interstitial fluid substantially exceeds circulating plasma levels, suggesting a concentrated local signalling role rather than dependence on hypothalamic supply (Nicholson & Hardy, 1992).

Oxytocin Receptors in Male Reproductive Tissues

Oxytocin receptors have been identified throughout the male reproductive tract. Autoradiographic and RT-PCR studies reveal OTR expression in the testis (Leydig and Sertoli cells), epididymis, vas deferens, prostate gland, and seminal vesicles (Whittington et al., 2001). Receptor density varies with reproductive status and is modulated by androgens – testosterone upregulates OTR expression in the epididymis, creating a synergistic relationship between the two hormonal systems (Filippi et al., 2002).

Oxytocin and Spermatogenesis

Modulation of Seminiferous Tubule Contractility

Spermatogenesis – the production of mature spermatozoa – depends on the coordinated transport of developing germ cells through the seminiferous tubules. Oxytocin stimulates rhythmic contractions of the myoid (peritubular) cells surrounding these tubules, facilitating sperm transport from the basal to the luminal compartment. Nieschlag and colleagues (1982) showed that OT administration increased intratesticular pressure and seminiferous tubule contractility in a dose-dependent manner in rats.

This contractile function is not merely mechanical. By accelerating the movement of immature spermatids toward the tubular lumen, oxytocin influences the efficiency of spermatogenesis itself. Disruption of OT signalling – through receptor antagonists or genetic knockout – results in impaired sperm output and altered tubular fluid dynamics (Assinder et al., 2000).

Steroidogenic Effects: Oxytocin and Testosterone

Oxytocin modulates Leydig cell steroidogenesis, though the direction of effect depends on species and experimental conditions. In rat Leydig cell cultures, OT potentiates human chorionic gonadotropin (hCG)-stimulated testosterone production at physiological concentrations (Nicholson & Hardy, 1992). The mechanism involves activation of the phospholipase C pathway via OTR-Gq coupling, increasing intracellular calcium and diacylglycerol – second messengers that enhance the steroidogenic acute regulatory protein (StAR) pathway.

In the ram – where much of the foundational work on testicular OT was performed – oxytocin and testosterone exhibit reciprocal regulation. Testosterone stimulates OT synthesis in Leydig cells, while OT enhances testosterone secretion, creating a positive feedback loop during the breeding season (Nicholson, 1996). This seasonal variation parallels fluctuations in sperm production, suggesting coordinated neuroendocrine control of male fertility.

Epididymal Contractions and Sperm Maturation

The epididymis serves as the site of sperm maturation, storage, and transport. Oxytocin is a potent stimulant of epididymal smooth muscle, driving peristaltic contractions that propel spermatozoa from the caput (head) through the corpus (body) to the cauda (tail), where they are stored until ejaculation. Hib (1994) demonstrated that oxytocin increases the frequency and amplitude of spontaneous contractions in isolated rat epididymal preparations.

The functional significance of this contractile activity extends beyond simple transport. During their epididymal transit, spermatozoa undergo critical biochemical modifications – membrane remodelling, acquisition of motility, and changes in surface glycoproteins – that confer fertilising capacity. By regulating transit time through OT-mediated contractions, oxytocin indirectly influences sperm maturation quality. Excessively rapid or slow transit is associated with reduced fertility (Filippi et al., 2002).

Coordination with Autonomic Innervation

Epididymal contractions are jointly regulated by oxytocin and the sympathetic nervous system. Noradrenergic nerves provide tonic contractile drive, while oxytocin – released both locally and from the posterior pituitary during sexual arousal – provides a modulatory overlay. The two systems converge on smooth muscle calcium signalling, with OT acting via IP3-mediated calcium release from the sarcoplasmic reticulum, distinct from the noradrenaline-mediated L-type calcium channel pathway (Whittington et al., 2001).

Prostatic Function and Oxytocin

Growth Regulation of the Prostate

Oxytocin receptors are abundantly expressed in the human prostate, and OT has been implicated in both normal prostatic growth and pathological hyperplasia. Bodanszky et al. (1992) first reported that oxytocin stimulates contraction of prostatic smooth muscle, contributing to the expulsion of prostatic secretions during ejaculation. Later work by Whittington et al. (2001) showed that OT acts as a growth factor for prostatic stromal cells, stimulating proliferation via activation of MAP kinase pathways.

This mitogenic role has clinical implications. Elevated prostatic OTR expression has been observed in benign prostatic hyperplasia (BPH), suggesting that dysregulated oxytocin signalling may contribute to prostatic enlargement in ageing men. However, the relationship is complex – OT also induces differentiation in some cell types, and its net effect on prostate growth likely depends on the balance between proliferative and differentiative signals (Nicholson & Whittington, 2007).

Prostatic Secretory Function

The prostate contributes approximately 30% of seminal fluid volume, secreting enzymes (prostatic acid phosphatase, prostate-specific antigen), zinc, citrate, and polyamines essential for sperm viability. Oxytocin stimulates prostatic epithelial secretion in organ culture experiments, and OT levels in seminal plasma correlate positively with prostatic secretory markers (Bodanszky et al., 1992). This secretory role complements OT’s contractile function – the peptide simultaneously promotes both the production and the mechanical expulsion of prostatic fluid during the ejaculatory process.

Oxytocin During Male Sexual Arousal and Orgasm

Plasma Oxytocin Levels During the Sexual Response

Circulating oxytocin levels rise markedly during male sexual arousal and peak at orgasm. Carmichael et al. (1987) conducted the seminal study on this topic, measuring plasma OT in men during masturbation-induced orgasm. They reported a multi-fold increase in OT concentration, with levels peaking within 1–2 minutes of orgasm and returning to baseline within 5–10 minutes. This pulsatile release pattern mirrors the oxytocin surge observed during the milk ejection reflex in lactating women, suggesting a common neurosecretory mechanism.

Subsequent studies confirmed these findings and extended them. Murphy et al. (1987) demonstrated that the magnitude of the OT surge correlates with subjective orgasm intensity, and Blaicher et al. (1999) showed that OT levels increase during penile erection prior to orgasm, implicating the peptide in the arousal phase as well as the climactic phase of sexual response.

Functional Role in Ejaculation

The oxytocin surge at orgasm serves multiple functional purposes in the ejaculatory process. OT stimulates contractions of the vas deferens, seminal vesicles, and prostatic smooth muscle – the coordinated muscular activity that constitutes the emission phase of ejaculation. Additionally, spinal cord oxytocin pathways contribute to the rhythmic contractions of the bulbospongiosus and ischiocavernosus muscles during the expulsion phase (Argiolas & Melis, 2004).

Intrathecal administration of OT in animal models accelerates ejaculatory latency, while OT receptor antagonists delay or inhibit ejaculation, providing causal evidence for OT’s role in this reflex (Argiolas & Melis, 2004). The clinical relevance is notable: men with premature ejaculation show elevated baseline OT levels compared to controls, suggesting that heightened oxytocinergic tone may lower the ejaculatory threshold (Cera et al., 2021).

Central Mechanisms: Oxytocin and Sexual Motivation

Beyond peripheral reproductive effects, centrally released oxytocin modulates sexual motivation and erectile function via hypothalamic and limbic pathways. OT neurons in the paraventricular nucleus (PVN) project to the spinal cord and to brain regions involved in sexual behaviour, including the ventral tegmental area and medial preoptic area. Central OT administration induces penile erection in rats – an effect mediated by downstream dopaminergic and nitrergic (NO-producing) neurons (Melis et al., 2007).

This central pro-erectile pathway operates via OTR activation in the PVN, triggering a neural cascade that ultimately increases nitric oxide release in the corpus cavernosum. Melis et al. (2007) demonstrated that PVN oxytocin neurons are activated during copulation and that their inhibition impairs erectile responses, confirming a physiological role for central OT in male sexual function.

Clinical Perspectives

Oxytocin and Male Infertility

Given OT’s involvement in spermatogenesis, sperm transport, and steroidogenesis, there has been interest in its potential as a biomarker or therapeutic target in male infertility. Seminal plasma OT levels are lower in oligozoospermic men (low sperm count) compared to normozoospermic controls, suggesting that deficient paracrine OT signalling may contribute to impaired sperm production (Goverde et al., 1998). However, exogenous OT administration for infertility remains experimental, and the optimal dosing, route, and patient selection criteria are yet to be established.

Implications for Prostate Disease

The role of oxytocin in prostatic growth raises questions about OTR antagonists as potential therapeutic agents for BPH. Selective OTR blockade could theoretically reduce prostatic smooth muscle tone (improving urinary flow) while attenuating stromal proliferation. Preclinical data support this concept, but no OTR antagonist has progressed to clinical trials for BPH as of 2025 (Nicholson & Whittington, 2007).

Summary

Oxytocin – traditionally classified as a “female” reproductive hormone – is integral to male reproductive function at every level: from the paracrine regulation of testicular steroidogenesis and spermatogenesis, through epididymal sperm transport and prostatic secretion, to the neuroendocrine orchestration of sexual arousal and ejaculation. The presence of a complete OT/OTR signalling system throughout the male reproductive tract, operating in concert with androgens and the autonomic nervous system, underscores that oxytocin is a fundamental – not ancillary – component of male reproductive biology. As our understanding of this system deepens, new therapeutic avenues for conditions ranging from male infertility to prostatic disease may emerge. For a comprehensive overview, see our references page.

Frequently Asked Questions

References

1. Nicholson HD, Hardy MP. Luteinizing hormone differentially regulates the secretion of testicular oxytocin and testosterone by purified adult rat Leydig cells in vitro. Endocrinology. 1992;130(2):671-677.
2. Frayne J, Nicholson HD. Localization of oxytocin receptors in the human and macaque monkey male reproductive tracts: evidence for a physiological role of oxytocin in the male. Mol Hum Reprod. 1998;4(6):527-532.
3. Whittington K, Assinder SJ, Parkinson T, Lapwood KR, Nicholson HD. Function and localization of oxytocin receptors in the reproductive tissue of rams. Reproduction. 2001;122(2):317-325.
4. Filippi S, Vannelli GB, Granchi S, et al. Identification, localization and functional activity of oxytocin receptors in epididymis. Mol Cell Endocrinol. 2002;193(1-2):89-100.
5. Assinder SJ, Reber HA, Nicholson HD. Effects of oxytocin, 5α-dihydrotestosterone and testosterone on the peritubular and seminiferous tubule contractions of the rat testis in vitro. Adv Exp Med Biol. 2000;480:301-306.
6. Nicholson HD. Oxytocin: a paracrine regulator of prostatic function. Rev Reprod. 1996;1(2):69-72.
7. Hib J. The contractility of the cauda epididymidis of the mouse, its spontaneous motility and the effect of oxytocin. J Reprod Fertil. 1994;102(1):191-196.
8. Bodanszky M, Sharaf H, Roy JB, Said SI. Contractile activity of vasotocin, oxytocin, and vasopressin on mammalian prostate. Eur J Pharmacol. 1992;216(2):311-313.
9. Carmichael MS, Humbert R, Dixen J, Palmisano G, Greenleaf W, Davidson JM. Plasma oxytocin increases in the human sexual response. J Clin Endocrinol Metab. 1987;64(1):27-31.
10. Murphy MR, Seckl JR, Burton S, Checkley SA, Lightman SL. Changes in oxytocin and vasopressin secretion during sexual activity in men. J Clin Endocrinol Metab. 1987;65(4):738-741.
11. Blaicher W, Gruber D, Bieglmayer C, Blaicher AM, Knogler W, Huber JC. The role of oxytocin in relation to female sexual arousal. Gynecol Obstet Invest. 1999;47(2):125-126.
12. Argiolas A, Melis MR. The role of oxytocin and the paraventricular nucleus in the sexual behaviour of male mammals. Physiol Behav. 2004;83(2):309-317.
13. Melis MR, Succu S, Sanna F, et al. Oxytocin injected into the ventral subiculum or the posteromedial cortical nucleus of the amygdala induces penile erection and increases extracellular dopamine levels in the nucleus accumbens of male rats. Eur J Neurosci. 2007;26(4):1026-1035.
14. Goverde HJ, Bisseling JG, Wetzels AM, et al. A neuropeptide in human semen: oxytocin. Arch Androl. 1998;41(1):17-22.
15. Nicholson HD, Whittington K. Oxytocin and the human prostate in health and disease. Int Rev Cytol. 2007;263:253-286.
16. Cera N, Castelhano J, Oliveira C, et al. The role of oxytocin in premature ejaculation – a systematic review. Sex Med Rev. 2021;9(3):456-469.